FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tetsuya Yamagata

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Hematopoietic Stem Cells

Physiology

Co-author Network

Publications

TOP 3
Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
Wataru Takahashi; Yukihiro Arai; Jiro Tadokoro; Kengo Takeuchi; Tetsuya Yamagata; Kinuko Mitani
[Disappearance of a Philadelphia chromosome-positive clone and appearance of a -negative clone following treatment with imatinib mesylate in acute myelomonocytic leukemia].
Sachiko Seo; Takashi Asai; Toshiki Saito; Takahiro Suzuki; Yasuyuki Morishita; Tetsuya Nakamoto; Motoshi Ichikawa; Go Yamamoto; Masahito Kawazu; Tetsuya Yamagata; Ryuichi Sakai; Kinuko Mitani; Seishi Ogawa; Mineo Kurokawa; Shigeru Chiba; Hisamaru Hirai
Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tetsuya Yamagata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
Nature 2009;460(7257):904-8.
2006: Wataru Takahashi; Yukihiro Arai; Jiro Tadokoro; Kengo Takeuchi; Tetsuya Yamagata; Kinuko Mitani
[Disappearance of a Philadelphia chromosome-positive clone and appearance of a -negative clone following treatment with imatinib mesylate in acute myelomonocytic leukemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2006;47(2):111-4.
2005: Sachiko Seo; Takashi Asai; Toshiki Saito; Takahiro Suzuki; Yasuyuki Morishita; Tetsuya Nakamoto; Motoshi Ichikawa; Go Yamamoto; Masahito Kawazu; Tetsuya Yamagata; Ryuichi Sakai; Kinuko Mitani; Seishi Ogawa; Mineo Kurokawa; Shigeru Chiba; Hisamaru Hirai
Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(6):3492-501.
2005: Kazuhiro Maki; Tetsuya Yamagata; Takashi Asai; Ieharu Yamazaki; Hideaki Oda; Hisamaru Hirai; Kinuko Mitani
Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.
Blood 2005;106(6):2147-55.
2004: Tetsuya Nakamoto; Akiko Shiratsuchi; Hideaki Oda; Keiichi Inoue; Tomoko Matsumura; Motoshi Ichikawa; Toshiki Saito; Sachiko Seo; Kazuhiro Maki; Takashi Asai; Takahiro Suzuki; Akira Hangaishi; Tetsuya Yamagata; Shinichi Aizawa; Masaki Noda; Yoshinobu Nakanishi; Hisamaru Hirai
Impaired spermatogenesis and male fertility defects in CIZ/Nmp4-disrupted mice.
Genes to cells : devoted to molecular & cellular mechanisms 2004;9(6):575-89.
2004: Yuko Yamaguchi; Mineo Kurokawa; Yoichi Imai; Koji Izutsu; Takashi Asai; Motoshi Ichikawa; Go Yamamoto; Eriko Nitta; Tetsuya Yamagata; Kazuki Sasaki; Kinuko Mitani; Seishi Ogawa; Shigeru Chiba; Hisamaru Hirai
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
The Journal of biological chemistry 2004;279(15):15630-8.
2004: Motoshi Ichikawa; Takashi Asai; Toshiki Saito; Sachiko Seo; Ieharu Yamazaki; Tetsuya Yamagata; Kinuko Mitani; Shigeru Chiba; Seishi Ogawa; Mineo Kurokawa; Hisamaru Hirai
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Nature medicine 2004;10(3):299-304.
2003: Kazuo Waga; Yuichi Nakamura; Kazuhiro Maki; Honoka Arai; Tetsuya Yamagata; Ko Sasaki; Mineo Kurokawa; Hisamaru Hirai; Kinuko Mitani
Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
Oncogene 2003;22(1):59-68.
2001: Keiki Kumano; Shigeru Chiba; Kiyoshi Shimizu; Tetsuya Yamagata; Noriko Hosoya; Toshiki Saito; Tokiharu Takahashi; Yoshio Hamada; Hisamura Hirai
Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression.
Blood 2001;98(12):3283-9.
2000: Kinuko Mitani; Tetsuya Yamagata; C Iida; H Oda; Kazuhiro Maki; M Ichikawa; Takashi Asai; Hiroaki Honda; Mineo Kurokawa; Hisamura Hirai
Nonredundant roles of the elongation factor MEN in postimplantation development.
Biochemical and biophysical research communications 2000;279(2):563-7.
2000: Tetsuya Yamagata; Kinuko Mitani; Hiromi Oda; Takahiro Suzuki; H Honda; Takashi Asai; K Maki; Tetsuya Nakamoto; Hisamura Hirai
Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs.
The EMBO journal 2000;19(17):4676-87.
2000: Mineo Kurokawa; Kinuko Mitani; Tetsuya Yamagata; Tokiharu Takahashi; Koji Izutsu; Seishi Ogawa; T Moriguchi; E Nishida; Yoshio Yazaki; Hisamura Hirai
The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
The EMBO journal 2000;19(12):2958-68.
1999: Toshiki Saito; Tetsuya Yamagata; Tokiharu Takahashi; Hiroaki Honda; Hisamura Hirai
ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma.
Biochemical and biophysical research communications 1999;260(2):329-31.
1999: Kazuhiro Maki; Kinuko Mitani; Tetsuya Yamagata; Mineo Kurokawa; Yoshinobu Kanda; Yoshio Yazaki; Hisamura Hirai
Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia.
Blood 1999;93(10):3216-24.
1998: Yoshinobu Kanda; Kinuko Mitani; Mineo Kurokawa; Tetsuya Yamagata; Yoshio Yazaki; Hisamura Hirai
Overexpression of the MEN/ELL protein, an RNA polymerase II elongation factor, results in transformation of Rat1 cells with dependence on the lysine-rich region.
The Journal of biological chemistry 1998;273(9):5248-52.
1998: Hiroo Ueno; Kazuki Sasaki; Hiroaki Honda; Tetsuya Nakamoto; Tetsuya Yamagata; Kiyoshi Miyagawa; Kinuko Mitani; Yoshio Yazaki; Hisamura Hirai
c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.
Blood 1998;91(1):46-53.
1997: Hiroo Ueno; Hiroaki Honda; Tetsuya Nakamoto; Tetsuya Yamagata; Kazuki Sasaki; Kiyoshi Miyagawa; Kinuko Mitani; Yoshio Yazaki; Hisamura Hirai
The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.
Oncogene 1997;14(25):3067-72.
1997: H Odai; Kazuki Sasaki; A Iwamatsu; Tetsuya Nakamoto; Hiroo Ueno; Tetsuya Yamagata; Kinuko Mitani; Yoshio Yazaki; Hisamura Hirai
Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
Blood 1997;89(8):2745-56.
1996: Tetsuya Yamagata; Kinuko Mitani; Yoshinobu Kanda; Y Yazaki; H Hirai
Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.
British journal of haematology 1996;94(2):370-2.